Key result
Benign cardiac tumors benefit from surgical resection, whereas malignant tumors require multimodal management.
This review provides a comprehensive overview of the clinical presentation, imaging, and management of rare primary and secondary cardiac tumors.
Answers are grounded in this paper and cite their sources.
May inform rare cardiac tumor cases; leaves open need for prospective validation of strategies.
Cardiac tumors are rare and encompass a variety of presentations. Clinica symptoms are usually nonspecific, but they can present as obstructive, embolic, or constitutional symptoms. Treatment options and prognosis vary highly depending on the subtype, tumor size, and location. Surgical resection is usually the first-line therapy, except for cardiac lymphomas, and provides favorable long-term prognosis in most benign tumors. Cardiac sarcomas, however, are usually diagnosed in advanced stages, and the treatment relies on a multimodal approach with chemotherapy and radiotherapy. Metastatic cardiac tumors are usually related to advanced disease and carry an overall poor prognosis.
No takes yet. Share an insight, caveat, or question.
Karigyo et al. (2024) conducted a review in Cardiac tumors. Cardiac tumors are rare neoplasms with highly variable presentations and prognoses, where benign tumors generally benefit from surgical resection and malignant tumors require a multimodal approach.
Synapse has enriched 10 related papers. Consider them for comparative context: